Biodefense is a public health imperative where timely medical countermeasures
are needed to improve survival and minimize morbidity in disaster situations.
The sporicidal, bactericidal, and viricidal activity of MPO and EPO,
combined with stability and portability, suggest the potential for multiple
uses in preventing infections in conventional and biological attack, and
other catastrophic situations.
A recent study by Exoxemis suggests that the MPO system may be useful
in the prevention of anthrax and other infections caused by biowarfare
agents. In vitro exposure of vegetative and spore forms of Bacillus species
to the MPO enzyme system showed 100% kill of Bacillus spores within within
120 minutes. more
Product platform for easy portability and administration
Our technologies provide a platform for the development of products that
include wound treatments, skin protectants and decontaminants, and respiratory
agents. MPO enzyme formulations are active in gel, spray, ointment, and
solution formulations that can be packaged for easy portability and on-site